Your browser doesn't support javascript.
loading
Cytomegalovirus (CMV)
Vikash, G. Lala; Mahomed, A. D.
  • Vikash, G. Lala; s.af
  • Mahomed, A. D; s.af
S. Afr. gastroenterol. rev ; 16(3): 23-26, 2018.
Article in English | AIM | ID: biblio-1270161
ABSTRACT
Cytomegalovirus (CMV) is a member of the Herpes virus group. It is a double stranded DNA virus and is known as Human Herpes Virus 5 in human hosts. CMV seropositivity is frequent in Western populations with a seroprevalence of 58% being reported in the U.S.1 In Africa, pooled prevalence studies demonstrate rates as high as 81.8% amongst HIV uninfected adults. Amongst the HIV infected population prevalence rates of 81.9% and 94.8% were seen in AIDS and asymptomatic HIV positive patients respectively.2 This is likely a reflection of impaired humoral immunity amongst those with AIDS. In a rural South African cohort, a 100% seroprevalence was demonstrated amongst HIV positive treatment naïve patients with a negative association noted between CD4 counts and IgG titres.3
Subject(s)
Search on Google
Index: AIM (Africa) Main subject: South Africa / Cytomegalovirus Vaccines Type of study: Risk factors Country/Region as subject: Africa Language: English Journal: S. Afr. gastroenterol. rev Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: AIM (Africa) Main subject: South Africa / Cytomegalovirus Vaccines Type of study: Risk factors Country/Region as subject: Africa Language: English Journal: S. Afr. gastroenterol. rev Year: 2018 Type: Article